Full Text
The Full Text of this article is available as a PDF (294.4 KB).
. 1997 Sep;44(3):215–218. doi: 10.1046/j.1365-2125.1997.t01-1-00582.x
The Clinical Section of the British Pharmacological Society: prospects for the future
Nigel S
Baber
1, Geoff T
Tucker
2, David J
Webb
3
Nigel S Baber
1
Chairman, Clinical Section, British Pharmacological Society and International Medical Director, GlaxoWellcome Research & Development Ltd, Greenford Road, Greenford, Middlesex UB6 0HE, ,
Find articles by Nigel S
Baber
Geoff T Tucker
2
Chairman, British Journal of Clinical Pharmacology, University of Sheffield, Department of Medicine & Pharmacology, Floor L , Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF and ,
Find articles by Geoff T
Tucker
David J Webb
3
Secretary, Clinical Section, British Pharmacological Society and Christison Professor of Therapeutics & Clinical Pharmacology, Clinical Pharmacology Unit and Research Centre, The University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU
Find articles by David J
Webb
1
Chairman, Clinical Section, British Pharmacological Society and International Medical Director, GlaxoWellcome Research & Development Ltd, Greenford Road, Greenford, Middlesex UB6 0HE, ,
2
Chairman, British Journal of Clinical Pharmacology, University of Sheffield, Department of Medicine & Pharmacology, Floor L , Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF and ,
3
Secretary, Clinical Section, British Pharmacological Society and Christison Professor of Therapeutics & Clinical Pharmacology, Clinical Pharmacology Unit and Research Centre, The University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU
✉
Correspondence to: Professor D. J. Webb Clinical Pharmacology Unit and Research Centre, The University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU.
PMCID: PMC2042836 PMID: 9296314